US SEC Filings Daily Market Digest — June 17, 2026

17-06-2026

17 Education & Technology Group Inc. reported its unaudited first quarter 2026 financial results via a press release furnished as an exhibit to this Form 6-K filing. The filing covers results for the quarter ended March 31, 2026.

• · The filing was made on June 17, 2026.
• · The press release (Exhibit 99.1) contains unaudited financial results for the first quarter of 2026.
• · The company is a foreign private issuer filing under Form 6-K.
• · The principal executive office is located in Beijing, China.

17-06-2026

This 20-F filing is an annual report detailing Takeda's extensive pipeline across multiple therapeutic areas. The report highlights several recent regulatory milestones including approvals and filings for key assets such as ADZYNMA (congenital TTP) in China, VONVENDI/VEYVONDI (von Willebrand disease) in Japan, EU, and the U.S., and multiple immunoglobulin products (TAK-961, TAK-339, TAK-771, TAK-880) in Japan and elsewhere. However, the pipeline also shows many assets in early-to-mid-stage trials (Phase I/II) and some programs in earlier development without concrete near-term catalysts, highlighting the balanced risk profile of a large pharma pipeline.

• · TAK-279 (zasocitinib) is in Phase III for psoriasis globally and also in Phase III for pediatric psoriasis, Phase III for psoriatic arthritis, but only Phase IIb for Crohn's disease, ulcerative colitis, and vitiligo, and Phase IIa for hidradenitis suppurativa.
• · TAK-079 (mezagitamab) is in Phase III for immune thrombocytopenia and IgA nephropathy globally.
• · TAK-227/ZED1227 is only in Phase IIb for celiac disease.
• · TAK-101 is only in Phase II for celiac disease.
• · TAK-781 is in Phase I for primary sclerosing cholangitis.
• · TAK-755 is only in Phase II for acute ischemic stroke.
• · TAK-360 is in Phase II for idiopathic hypersomnia and narcolepsy type 2.
• · TAK-495 is in Phase I and has disclosed no specific indication.
• · TAK-853 is filed in Japan for platinum-resistant ovarian cancer but only in Phase III for platinum-sensitive ovarian cancer.
• · TAK-226 is in Phase III globally for 2L MDS anemia but only in Phase II for anemia-associated myelofibrosis.
• · TAK-928/IBI363 is in Phase III for 2L squamous NSCLC but only in Phase II for solid tumors.
• · TAK-921/IBI343 is in Phase III for 3L gastric cancer in Japan and China but only in Phase I for solid tumors.
• · TAK-168/KQB168 and TAK-188 are both in Phase I for solid tumors.
• · TAK-330 is in Phase III in the U.S. for DOAC reversal in surgical settings.
• · TAK-881 is in Phase III for primary immunodeficiencies and CIDP across U.S., EU, and Japan.
• · TAK-411 is only in Phase II for CIDP.
• · HQP1351 is in Phase III for CML in U.S., EU, and Japan.
• · ACI-24.060 is in Phase II for Alzheimer's disease.
• · IBI3001 is in Phase I for solid tumors.

17-06-2026

Aegon Ltd. announced leadership changes and selected New York City as the location for its future corporate headquarters, ahead of its planned redomiciliation from Bermuda to the United States. Will Fuller will be appointed President and COO effective January 1, 2027, and CEO Lard Friese will relocate to the U.S. in early 2027. No financial metrics were disclosed; the announcement is purely strategic and organizational.

• · Will Fuller will become President and COO effective January 1, 2027, reporting to CEO Lard Friese.
• · Lard Friese will relocate to the United States at the beginning of 2027.
• · New York City headquarters office expected to open in mid-2027.
• · An extraordinary general meeting of shareholders is contemplated in Q4 2026 to approve the redomiciliation.
• · Aegon is currently domiciled in Bermuda, headquartered in Schiphol, Netherlands, and listed on Euronext Amsterdam and NYSE.

17-06-2026

POMDOCTOR LIMITED announced that its ADS ratio change will become effective on June 22, 2026, converting the current ratio of 1 ADS representing 1/6 Class A ordinary share to 1 ADS representing 3 Class A ordinary shares. This change effectively acts as a one-for-eighteen reverse ADS split, with no change to the underlying Class A ordinary shares. The Company expects the ADS trading price to increase proportionally, but cautions that it cannot guarantee the post-change price will be equal to or greater than eighteen times the pre-change price.

• · The ADS Ratio Change will be effective on June 22, 2026, U.S. Eastern Time.
• · The new CUSIP number for the ADSs will be 73181R207.
• · No fractional new ADSs will be issued; fractional entitlements will be sold and net cash proceeds distributed to holders.
• · The Company ranks sixth on China’s Internet hospital market based on the number of contracted doctors in 2022, according to Frost & Sullivan.

17-06-2026

NeoGenomics, Inc. announced the pricing of an offering of convertible senior notes due 2032 to qualified institutional buyers on June 17, 2026. The filing does not disclose the size, interest rate, or conversion terms of the offering, nor does it provide any financial results or operational updates.

• · The offering is made only to qualified institutional buyers under Rule 144A.
• · The notes are due in 2032.
• · The press release detailing the pricing is filed as Exhibit 99.1.

17-06-2026

Alterity Therapeutics Ltd filed a Form 6-K with the SEC on June 17, 2026, reporting changes in director's interests. The filing includes two Change of Director's Interest Notices as exhibits. No financial results or material operational updates were disclosed.

• · The filing incorporates by reference into several existing SEC registration statements (Forms S-8 and F-3).
• · Exhibits include two Change of Director's Interest Notices (Exhibit 99.1).

17-06-2026

Magnum Ice Cream Co N.V. filed a Form 6-K on June 17, 2026, disclosing the grant of stock options to six key executives on June 16, 2026. The options were granted at exercise prices of €15.33 (EUR) and £13.23 (GBP), with the largest grants going to CFO Abhijit Bhattacharya (1,330,010 options, total €20.4M) and CHRO Ronald Schellekens (1,071,235 options, total £14.2M). The filing is a routine PDMR notification and does not contain any financial results or performance data.

• · All transactions occurred on June 16, 2026, outside a trading venue.
• · The options are for ordinary shares of €3.50 each, ISIN NL0015002MS2.
• · The grant to CFO Abhijit Bhattacharya is the largest by both volume (1,330,010 options) and total value (€20,389,053.30).
• · The grant to CHRO Ronald Schellekens is the second largest by volume (1,071,235 options) and total value (£14,172,439.05).
• · The smallest grant was to Victoria McKenzie-Gould (48,212 options, €739,089.96).

17-06-2026

This 6-K filing reports the results of shareholder votes on two agenda items at Korea Electric Power Corp, with overwhelming approval of 97.4% on Item 1 (both sub-items) and 99.1% / 98.8% on Item 2 sub-items. No specific financial performance or business updates are included.

• · Item 1 was voted on two sub-items: 1-1 and 1-2, each with the same outstanding share count (641,964,077) and attendant shares (437,575,526).
• · Item 2 sub-items had smaller share counts: 326,879,901 outstanding and 122,491,350 attendant shares.
• · Approval percentages were uniformly high, ranging from 97.4% to 99.1%.
• · The filing does not disclose the specific topics of the agenda items or any financial figures.

17-06-2026

JBDI Holdings Ltd (Nasdaq: JBDI) received a Nasdaq determination letter on January 7, 2026, for non-compliance with the minimum bid price rule (closing below $1 per share for 30 consecutive business days). To regain compliance by the July 6, 2026 deadline, the company announced a 1-for-2 reverse stock split effective June 25, 2026. If compliance is not achieved and an additional grace period is not granted, the company's shares may be delisted.

• · The reverse stock split is expected to be effective on or about June 25, 2026, with a record date of June 25, 2026.
• · Trading on a split-adjusted basis under the ticker 'JBDI' is expected to begin on the trading day following the effective date.
• · If the company fails to regain compliance by July 6, 2026, and is ineligible for an additional grace period, Nasdaq will issue a delisting notice; the company may appeal to a hearings panel.

17-06-2026

Wing Yip Food Holdings Group Ltd (Nasdaq: WYHG) announced on June 16, 2026 that it regained compliance with Nasdaq's minimum bid price rule (Listing Rule 5550(a)(2)). The company's ADS closing bid price had been below $1.00 for 30 consecutive business days as of December 22, 2025, but subsequently closed at or above $1.00 for 10 consecutive business days from June 2 to June 15, 2026, resolving the deficiency.

• · Wing Yip's ordinary shares have been listed on the Korea Securities Dealers Automated Quotations (KOSDAQ) of the Korea Exchange since 2018.
• · The company sells products through self-operated stores, distributors, and e-commerce platforms in over 18 provinces across mainland China.
• · The Wing Yip brand traces its history back to 1915.

17-06-2026

Organon & Co. is soliciting stockholder approval for its acquisition by Sun Pharmaceutical Industries Ltd. via a merger with Sun Pharma USA's subsidiary, with stockholders to vote on the Merger Agreement Proposal and a non-binding advisory Compensation Proposal at a Special Meeting on July 23, 2026. The Board unanimously recommends voting FOR both proposals, and the merger consideration is based on the terms of the Merger Agreement dated April 26, 2026. Stockholders who fail to vote or abstain will effectively count as votes against the Merger Agreement Proposal, which requires approval by a majority of outstanding shares.

• · The Special Meeting will be held virtually on July 23, 2026 at 10:00 a.m. Eastern Time.
• · Record date for voting is June 15, 2026.
• · Approval of the Merger Agreement Proposal requires the affirmative vote of holders of a majority of outstanding shares of Organon common stock entitled to vote.
• · The Merger Agreement was dated April 26, 2026.
• · Organon was formed through a spinoff from Merck & Co., Inc. in 2021.
• · Organon's principal executive offices are at 30 Hudson Street, Floor 33, Jersey City, New Jersey 07302.
• · Sun Pharma USA's principal executive offices are at 2 Independence Way, Princeton, NJ 08540.
• · Merger Sub has not engaged in any business or operations except activities incidental to its formation and the merger.

17-06-2026

Holcim Ltd. and its affiliate Inversiones ASPI S.A. filed an amended Schedule 13D disclosing beneficial ownership of 211,985,547 common shares (50.01%) of Cementos Pacasmayo SAA as of June 16, 2026. On June 15, 2026, Holcim's Executive Committee determined to proceed with a public tender offer for any and all outstanding common shares, indicating a potential full acquisition.

• · The filing is an amendment to the original Schedule 13D filed on April 4, 2026.
• · The public tender offer will be for any and all issued and outstanding common shares.
• · The ownership percentage is based on 423,868,449 common shares outstanding as of June 16, 2026.

17-06-2026

Toyota Motor Corporation's filing details its governance structure, strategic equity investments, and executive compensation framework. The company holds significant stakes in partners such as NTT, MS&AD Insurance, and MUFG for smart city, mobility AI, and financial service collaborations, while recently selling a portion of its MS&AD and MUFG holdings. Toyota's compensation metrics show strong performance on operating income (STI at 134% of a ¥2.5 trillion reference value) but ROE evaluation is benchmarked at only 8%, indicating room for improved capital efficiency.

• · Toyota's board determined Hiromi Osada independent despite her past executive role at Chunichi Shimbun, citing immaterial business transactions (<0.2% of consolidated sales in last 3 years).
• · Ownership in Bridgestone Corporation increased due to a return from retirement benefit trust.
• · Positions in Grab, Pony AI, Uber, Aurora, Inchcape, and Yamato are held with 'No' voting rights limitations.
• · LTI uses a 5-year total shareholder return comparison against TOPIX (reference: 202.2%) and ROE benchmark of 8%.

17-06-2026

AerSale Corp held its Annual Meeting on June 11, 2026, with 93.2% of outstanding shares represented. All seven director nominees were elected, and shareholders approved the advisory say-on-pay proposal, the redomestication from Delaware to Texas, and the ratification of Grant Thornton LLP as auditor. However, the say-on-pay proposal received only 57.3% support, indicating significant shareholder dissent on executive compensation.

• · All seven director nominees were elected with votes ranging from 30,564,322 (Fedder) to 37,052,271 (Mitchell) in favor.
• · The redomestication proposal passed with 26,727,131 votes for and 12,926,608 against (67.4% support).
• · Ratification of Grant Thornton LLP as auditor passed overwhelmingly with 42,907,551 votes for (97.5% of votes cast).
• · Broker non-votes totaled 4,312,157 on Items 1, 2, and 3, but none on Item 4 (ratification of auditor).

17-06-2026

Evotec SE filed a Form 6-K on June 17, 2026, reporting a directors' dealing transaction by Dr. Cord Dohrmann, who sold shares on June 16, 2026. The filing provides no financial results or operational updates, and no quantitative performance data is disclosed.

• · The transaction was a sell by Dr. Cord Dohrmann, disclosed as a directors' dealing.
• · The filing was submitted under Rule 13a-16 or 15d-16 for the month of June 2026.
• · The report was signed by CEO Christian Wojczewski on June 17, 2026.

17-06-2026

Scinai Immunotherapeutics Ltd. held its Annual Meeting of Shareholders on June 16, 2026, with a quorum of 2,544,796,000 ordinary shares (636,199 ADSs). All eight proposals were approved by shareholders, including the re-election of directors, an amendment to increase authorized ordinary shares, and executive compensation matters. The meeting demonstrated strong shareholder support, with most proposals receiving over 90% of votes cast in favor.

• · Proposal 3 to increase authorized ordinary shares passed with 83.5% in favor, indicating shareholder support for potential future capital raising.
• · Proposal 7 (RSU grant to Chairman Germain for special recent efforts) received the lowest approval percentage at 89.9%, with 9.0% against.
• · All proposals passed with no significant opposition; the highest 'against' vote was 9.7% for Proposal 3.

17-06-2026

HDFC Bank Ltd. has issued USD 750 million in senior unsecured bonds, as disclosed in a Form 6-K filing with the SEC on June 17, 2026. The filing does not provide any comparative financial data or performance metrics, so no period-over-period analysis is possible.

• · The bonds are senior unsecured and denominated in USD.
• · The filing was made under Form 6-K for the month of June 2026.
• · The report is signed by Ajay Agarwal, Company Secretary and Group Head – Secretarial & Group Oversight.

17-06-2026

X Financial (XYF) filed a Form 6-K on June 17, 2026, announcing a leadership change. The filing does not provide details on the nature of the change, but it is signed by Yue (Justin) Tang as Chairman and Chief Executive Officer.

• · The leadership change is referenced in Exhibit 99.1, but the specific details of the change are not included in the filing text.

17-06-2026

Comstock Inc. filed an 8-K on June 17, 2026, announcing its participation in the Planet MicroCap Las Vegas 2026 conference. CEO Corrado De Gasperis and CFO Judd Merrill will present and meet with investors. The investor presentation materials are available on the company's website.

• · Conference: Planet MicroCap Las Vegas 2026 at Bellagio Resort & Hotel.
• · Materials available at https://comstock.inc/investors.

17-06-2026

Ocean Capital Acquisition Corp completed its IPO of 11,500,000 units at $10.00 per unit on June 10, 2026, generating gross proceeds of $115,000,000. Simultaneously, the company completed a private placement of 150,000 units at $10.00 per unit, raising an additional $1,500,000. Total proceeds of $115,000,000 were placed in a trust account, including $4,025,000 in deferred underwriting commissions. No negative or flat metrics are present in this filing.

• · The IPO included full exercise of the underwriters' over-allotment option of 1,500,000 units.
• · Each warrant is exercisable for one ordinary share at $11.50 per share.
• · The trust account is maintained by Odyssey Transfer & Trust Company.
• · An audited balance sheet as of June 10, 2026 is included as Exhibit 99.1.

17-06-2026

At its Annual Meeting on June 11, 2026, Armstrong World Industries shareholders elected all nine director nominees, ratified KPMG LLP as auditor for fiscal 2026, approved the 2026 Directors Stock Unit Plan, and gave advisory approval of executive compensation. Following the meeting, the Board appointed committee members and chairs, including Barbara L. Loughran as Audit Chair, Roy W. Templin as Finance Chair, Wayne R. Shurts as Management Development & Compensation Chair, and Richard D. Holder as Nominating, Governance & Social Responsibility Chair. All proposals passed with strong shareholder support, with the lowest 'for' vote percentage being approximately 91.5% for director Richard D. Holder.

• · All nine director nominees received 'for' votes ranging from 33,617,902 (Richard D. Holder) to 36,447,673 (Mark A. Hershey).
• · Broker non-votes totaled 2,053,748 for each director election and for the advisory compensation vote and stock plan approval.
• · The ratification of KPMG had no broker non-votes and received 37,098,530 'for' votes, 1,559,588 'against', and 118,774 abstentions.
• · The 2026 Directors Stock Unit Plan received 36,119,326 'for', 482,889 'against', and 120,929 abstentions.
• · Advisory approval of executive compensation received 35,408,662 'for', 1,189,247 'against', and 125,235 abstentions.

17-06-2026

Dorman Products, Inc. entered into Amendment No. 3 to its Credit Agreement, effective June 16, 2026, which, among other changes, extends the maturity of the Revolving Credit Commitments and increases the aggregate Revolving Credit Commitments. The amendment is conditioned on the issuance of $450 million in 2034 Senior Notes, the proceeds of which will be used to prepay all outstanding Amendment No. 1 Term Loans and related fees and expenses. The amendment also involves the addition of new lenders and the departure of certain existing lenders.

• · The amendment involves the reallocation of Revolving Credit Loans and participations in Letters of Credit among Consenting Lenders, New Lenders, Increased Lenders, Decreased Lenders, and Departing Lenders.
• · The amendment also amends and restates several schedules and exhibits to the Original Credit Agreement, including Schedules 7.2, 7.18, 7.19, 8.12, 8.21, 9.1, 9.2, and 9.3.
• · The amendment adds new Exhibits J and K to the Credit Agreement.
• · The amendment is subject to the satisfaction of conditions including delivery of closing certificates, certificates of good standing, legal opinions, a solvency certificate, and compliance with PATRIOT Act and Beneficial Ownership Regulation requirements.

17-06-2026

News Corporation filed an 8-K on June 17, 2026, disclosing its ongoing stock repurchase program, under which it is authorized to buy back up to $1 billion in aggregate of its Class A and Class B common stock. The filing includes daily transaction disclosures provided to the Australian Securities Exchange (ASX) as required by ASX rules. The company notes that actual repurchases may vary due to market conditions, stock price, securities laws, and other factors, and it disclaims any obligation to update forward-looking statements.

• · The repurchase program authorizes up to $1 billion in aggregate for both Class A and Class B common stock.
• · Daily transaction disclosures are provided to the ASX under ASX rules.
• · The company also discloses repurchase program information in its quarterly and annual reports.
• · Forward-looking statements include intent to repurchase shares from time to time, subject to market conditions, stock price, securities laws, and alternative investment opportunities.

17-06-2026

Antero Resources Corporation has entered into a commercial paper dealer agreement under a 4(a)(2) program, dated June 16, 2026, to issue short-term promissory notes (Notes) with maturities not exceeding 397 days and a minimum face amount of $250,000. The program allows for sales to qualified institutional buyers and institutional accredited investors, with no obligation on either party to sell or purchase Notes. The filing does not disclose the maximum aggregate amount of the program or any specific financial terms, but establishes the framework for future note issuances.

• · The Notes are issued under an Issuing and Paying Agency Agreement dated June 16, 2026.
• · Notes may be issued as individual physical certificates or book-entry notes registered in the name of DTC.
• · The Issuer represents it is not currently issuing commercial paper under Section 3(a)(3) of the Securities Act and will segregate proceeds if it does so.
• · The Issuer agrees to omit the Dealer's name from public filings and redact identifying information.
• · No sale to any one purchaser shall be for less than $250,000 face amount.
• · The program is structured to rely on the Section 4(a)(2) exemption from registration under the Securities Act.

17-06-2026

DigitalOcean Holdings, Inc. held its 2026 Annual Meeting of Stockholders on June 15, 2026, where stockholders voted on three proposals. Warren Adelman and Pueo Keffer were elected as Class II directors, and the compensation of named executive officers was approved on a non-binding advisory basis. However, the ratification of PricewaterhouseCoopers LLP as independent auditor received overwhelming support with 93,181,571 votes for and only 62,446 against, while the advisory vote on executive compensation had 1,869,745 votes against and 93,040 abstentions, indicating some shareholder dissent.

• · The 2026 Annual Meeting was held on June 15, 2026, with the proxy statement filed on April 24, 2026.
• · Broker non-votes totaled 9,763,078 for both director elections and the executive compensation proposal.
• · The auditor ratification proposal had no broker non-votes, as it is considered a routine matter.
• · Warren Adelman received 66,745,757 votes for (79.8% of votes cast) and 16,844,074 withheld (20.2%).
• · Pueo Keffer received 70,066,785 votes for (83.8% of votes cast) and 13,523,046 withheld (16.2%).
• · Executive compensation approval had 81,627,046 votes for (97.6% of votes cast excluding broker non-votes), 1,869,745 against (2.2%), and 93,040 abstentions (0.1%).

17-06-2026

General Catalyst Global Resilience Merger Corp. filed an 8-K on June 17, 2026, reporting an event on June 16, 2026, under Items 8.01 (Other Events) and 9.01 (Financial Statements and Exhibits). The filing indicates a merger or acquisition event, but no specific financial figures, transaction details, or performance metrics were disclosed in the provided content.

• · Filing type: 8-K, dated June 17, 2026, for event on June 16, 2026.
• · Items reported: 8.01 (Other Events) and 9.01 (Financial Statements and Exhibits).
• · Company is a blank check company (SIC 6770) incorporated in the Cayman Islands (E9).
• · Securities listed: Units, Class A ordinary shares, and Redeemable Warrants (exercise price $11.50 per share).
• · No financial data, transaction terms, or performance comparisons were included in the extracted text.

17-06-2026

VisionWave Holdings entered a binding term sheet on June 12, 2026, to form a joint venture with Lucky Whale Production Limited to develop a Tier IV data center in Beth Shemesh, Israel. The proposed structure gives VisionWave a ~51% effective interest in the project in exchange for issuing ~$40M in common stock (all-share, no cash) to the land owner. However, the transaction is not yet definitive—it is subject to due diligence, definitive agreements, Nasdaq/stockholder approvals, and securing substantial additional financing—and the stock issuance would be dilutive to existing stockholders.

• · The Term Sheet is stated to be binding, but the transaction remains subject to completion of due diligence, definitive agreements, stockholder approval, SEC and Nasdaq approvals, and regulatory/third-party consents.
• · The consideration shares, together with other recent and pending equity issuances, will be dilutive to existing stockholders.
• · The Project requires substantial additional capital for construction, expected to be sourced through capital-markets activities or project-finance facilities, with no assurance of availability on acceptable terms.
• · The land owner has a put option exercisable for a limited period following completion of construction.
• · Sponsor will manage the project and appoint its CEO, subject to reserved matters requiring VisionWave's consent and a deadlock-resolution mechanism.
• · The Company is an emerging growth company and has elected not to use the extended transition period for complying with new or revised accounting standards.

17-06-2026

Natural Gas Services Group, Inc. (NGS) filed an 8-K on June 17, 2026, disclosing that it hosted a conference call on June 15, 2026, to announce the closing of its acquisition of Flatrock Compression Holdings LLC. The filing includes a transcript of the call as Exhibit 99.1. The company provides natural gas and electric compression equipment and services to the energy industry.

• · The conference call was previously announced and held on June 15, 2026.
• · The acquisition of Flatrock Compression Holdings LLC has closed.
• · NGS is headquartered in Southlake, Texas, with administrative offices in Midland, Texas, an assembly facility in Tulsa, Oklahoma, and service facilities in major U.S. oil and gas basins.
• · The filing is under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits).
• · The company's common stock trades on the NYSE under the symbol NGS.

17-06-2026

Chipotle Mexican Grill held its 2026 annual meeting on June 11, 2026, with 1,121,739,569 shares represented. Shareholders elected all ten director nominees, approved executive compensation on a nonbinding advisory basis, and ratified Ernst & Young LLP as the independent auditor for fiscal 2026. While all proposals passed, director Patricia Fili-Krushel received the highest against vote (27,300,189) among nominees, and the advisory say-on-pay proposal had 47,598,354 against votes, indicating notable shareholder dissent.

• · Director Patricia Fili-Krushel received the highest against vote among nominees: 27,300,189 against, with 995,825,973 for.
• · Advisory say-on-pay proposal had 973,639,399 for, 47,598,354 against, and 2,411,240 abstentions.
• · Ratification of Ernst & Young LLP passed with 1,050,087,750 for, 66,089,192 against, and 5,562,627 abstentions; no broker non-votes on this proposal.
• · Broker non-votes totaled 98,090,576 on director elections and the say-on-pay proposal.

17-06-2026

JFB Construction Holdings (JFB) filed an amended annual report (10-K/A) for the fiscal year ended December 31, 2025. Revenues grew 32.3% YoY to $30.5 million, driven largely by a surge in related-party sales (from $0.9 million to $5.9 million). However, the company swung from a net profit of $0.1 million in 2024 to a net loss of $5.3 million in 2025, as gross profit fell 37.4% due to cost-of-revenues increasing faster than sales and operating expenses rising 73.7%. Cash flow from operations turned sharply negative at -$11.8 million, though a large financing inflow (net $35.6 million) from stock and warrant issuances boosted cash to $25.2 million at year-end. Significant risks are disclosed including lack of public company experience, concentrated cash holdings, and no formal internal controls.

• · Operating cash flow was negative $11.8 million in FY2025 versus positive $3.5 million in FY2024.
• · The company raised approximately $39.5 million net from issuance of preferred stock (Series C) and $4.7 million from common stock issuance, while repurchasing and retiring all 8 million Class B common shares for $12.0 million.
• · Basic and diluted EPS was -$0.31 in FY2025 compared to $0.01 in FY2024.
• · Cost of revenues grew 51.7% YoY to $27.4 million, outpacing revenue growth.
• · Selling and marketing expenses surged from $51,635 to over $1.0 million, a 1,858% increase.
• · As of June 16, 2026, $10.8 million in cash was uninsured (above FDIC limit).
• · The company's accumulated deficit was $632,272 at Dec 31, 2025 versus $5.9 million accumulated surplus at Dec 31, 2024.

17-06-2026

Oklo Inc. reported a net loss of $33.1M for Q1 2026, widening from a $9.8M loss in Q1 2025, driven by a 187% increase in operating expenses to $51.2M. However, the company significantly strengthened its balance sheet, ending the quarter with $1.59B in cash and cash equivalents (up from $0.79B at year-end 2025) after raising $1.18B net from an at-the-market equity offering. Total assets more than doubled to $2.70B, while stockholders' equity rose to $2.64B from $1.48B.

• · Net loss per share (basic and diluted) was $(0.19) in Q1 2026 vs $(0.07) in Q1 2025.
• · Stock-based compensation surged to $15.6M in Q1 2026 from $2.3M in Q1 2025.
• · The company issued 12.4 million shares through an at-the-market offering, raising $1.18M net.
• · Capital expenditures on property, plant and equipment increased to $32.8M in Q1 2026 from $0.3M in Q1 2025.
• · Accumulated deficit grew to $(273.8M) as of March 31, 2026 from $(240.8M) at year-end 2025.
• · Total comprehensive loss was $(35.7M) in Q1 2026 vs $(10.4M) in Q1 2025.
• · The company had $0.9M in cash and equivalents at the end of Q1 2025, compared to $1.59M at the end of Q1 2026.

17-06-2026

Chief Medical Officer Scholl Hendrik Peter sold 3,140 American depositary share at $139.57 (~$438K). 8 transactions reported in total. Scholl Hendrik Peter holds 25,000 shares after the transaction.

• · Chief Medical Officer Scholl Hendrik Peter sold 2,054 American depositary share at $137.61 (~$283K)
• · Chief Medical Officer Scholl Hendrik Peter sold 784 American depositary share at $138.18 (~$108K)
• · Chief Medical Officer Scholl Hendrik Peter sold 3,140 American depositary share at $139.57 (~$438K)
• · Chief Medical Officer Scholl Hendrik Peter sold 540 American depositary share at $140.58 (~$75.9K)
• · Chief Medical Officer Scholl Hendrik Peter sold 100 American depositary share at $141.83 (~$14.2K)
• · Chief Medical Officer Scholl Hendrik Peter sold 450 American depositary share at $142.20 (~$64K)
• · Chief Medical Officer Scholl Hendrik Peter sold 1,897 American depositary share at $143.55 (~$272K)
• · Chief Medical Officer Scholl Hendrik Peter sold 1,035 American depositary share at $145.02 (~$150K)

17-06-2026

CEO Chen Xiangdong bought 73,801 ADS at $2.28 (~$168K). Chen Xiangdong holds 7,788,330 shares after the transaction.

• · CEO Chen Xiangdong bought 73,801 ADS at $2.28 (~$168K)

17-06-2026

Guardian Metal Resources PLC (GMTL) has acquired Lincoln Estates, securing 2,540 acre-feet per annum of water rights across three permits and approximately 841 acres of real property. The water rights are banked with the Lincoln County Water District, and the property is zoned for mixed use, commercial, industrial, and single-family development. This acquisition is positioned as a key derisking milestone for the advancement of the Tempiute project.

• · The real property is zoned for mixed use, commercial, industrial, and single family.
• · Direct access off Highway 375, the same access highway for Tempiute.
• · Guardian Metal retains the right to assign and/or transfer the beneficial interest in the water rights for use within the service area, which includes Tempiute.

17-06-2026

NOVONIX Ltd filed a Form 6-K with the SEC on June 17, 2026, attaching ASX announcements regarding a trading halt, a successful institutional placement, and the launch of a share purchase plan. The capital raising activities indicate the company is seeking additional funding, but no financial results or performance metrics are provided in this filing.

• · Trading halt requested on June 16, 2026.
• · Successful institutional placement announced on June 17, 2026.
• · Share Purchase Plan launched on June 17, 2026.
• · Appendix 3B filed on June 17, 2026.

17-06-2026

Nam Tai Property Inc. (NTPIF) disclosed the voting results from its shareholder meeting in a 6-K filing dated June 17, 2026. All six director nominees—Michael Cricenti, Bo Hu, Peter R. Kellogg, Ruigang Li, Tao Wang, and Chunhua Yu—were elected with overwhelming shareholder support, each receiving over 30.7 million votes for their election. However, a notable number of votes were cast against certain nominees, with Chunhua Yu receiving the highest opposition at 407,613 votes against, indicating some shareholder dissent.

• · All six director nominees were elected with votes for ranging from 30,734,176 to 30,963,688.
• · Chunhua Yu received the highest number of votes against at 407,613, while Bo Hu had the lowest opposition at 178,101.
• · There were no broker non-votes for any nominee.
• · Votes abstained ranged from 87,133 to 100,105 across nominees.

17-06-2026

VEON MidCo B.V., a subsidiary of VEON Ltd., announced the final results of its tender offer for its outstanding $1,013,973,000 3.375% Notes due 2027. A total of $936,022,000 in aggregate principal amount was validly tendered by the Early Tender Deadline, of which $886,075,000 was accepted (after scaling at a proration factor of 0.922911). No additional notes were tendered after the Early Tender Deadline, leaving $124,898,000 in notes outstanding after the final settlement. The tender offer successfully reduced the company's debt burden, but the remaining outstanding notes indicate that not all holders participated.

• · The tender offer was announced on 18 May 2026 and expired at 5:00 p.m. New York City time on 16 June 2026.
• · The New Financing Condition was satisfied on 2 June 2026.
• · No Notes were validly tendered after the Early Tender Deadline (2 June 2026) up to the Expiration Deadline.
• · The accepted Early Tendered Notes have been cancelled and will not be re-issued or re-sold.
• · The Tender Offer was subject to offer and distribution restrictions as described in the Tender Offer Memorandum.

17-06-2026

BlackRock, Inc. crossed a voting rights threshold in Smith & Nephew PLC, increasing its stake from 12.074433% to 12.235936% as of June 15, 2026. The holding represents 103,717,469 voting rights attached to shares, with no voting rights through financial instruments.

• · The threshold was crossed on June 15, 2026.
• · BlackRock holds no voting rights through financial instruments (0.000000%).
• · The increase from the previous notification is approximately 0.1615 percentage points.

17-06-2026

Four Seasons Education reported a significant turnaround for FY2026 (ended Feb 28, 2026) with net income attributable to the company of RMB 30.8M, compared to a net loss of RMB 0.6M in FY2025 and net income of RMB 2.8M in FY2024. Revenue grew slightly to RMB 254.4M from RMB 251.1M in FY2025, driven by learning services (+21% YoY), while tourism services declined 14% YoY. The company also reported a gain from deregistration of subsidiaries of RMB 8.8M and improved operating income to RMB 6.7M from a loss of RMB 15.7M in FY2025. However, cash and cash equivalents decreased significantly to RMB 136.2M from RMB 210.8M in FY2025.

• · Operating income improved to RMB 6.7M in FY2026 from a loss of RMB 15.7M in FY2025.
• · Total assets increased slightly to RMB 739.5M as of Feb 28, 2026 from RMB 731.1M a year earlier.
• · Total equity increased to RMB 514.8M from RMB 505.2M.
• · Long-term borrowings remained stable at RMB 81M (non-current) plus RMB 9M current portion as of Feb 28, 2026.
• · The company reported a gain from deregistration of subsidiaries of RMB 8.8M in FY2026.
• · Adjusted net income (non-GAAP) was RMB 28.3M in FY2026, up from RMB 2.4M in FY2025.
• · Share-based compensation expenses decreased to RMB 1.7M in FY2026 from RMB 5.0M in FY2025.
• · Unrealized holding gain in investments was RMB 2.4M in FY2026.
• · Realized gain in investments was RMB 3.9M in FY2026.
• · Interest income, net decreased to RMB 6.0M in FY2026 from RMB 16.2M in FY2025.

17-06-2026

Magnachip Semiconductor held its 2026 Annual Meeting on June 11, 2026, where stockholders approved the Amended and Restated 2020 Equity and Incentive Compensation Plan, increasing authorized shares by 3,000,000, and ratified EY Han Young as independent auditor for FY2026. All four director nominees were elected, and the advisory vote on executive compensation passed. However, the equity plan approval received only 73.5% of votes cast in favor (excluding broker non-votes), and the say-on-pay vote had 15.9% against, indicating notable shareholder dissent.

• · Record date for the meeting was April 21, 2026.
• · Four directors were elected to serve until the 2027 Annual Meeting.
• · Proposal 3 (ratification of auditor) received 22,467,959 votes for, 1,175,489 against, and 688,942 abstained, with no broker non-votes.
• · The equity plan approval had 13,328,072 for, 4,058,795 against, and 153,629 abstained, plus 6,791,894 broker non-votes.
• · Say-on-pay vote: 14,602,034 for, 2,791,527 against, 146,935 abstained, plus 6,791,894 broker non-votes.

17-06-2026

Director CERRONE GABRIELE M was awarded 15,000 COMMON STOCK at $1.11 (~$16.7K). CERRONE GABRIELE M holds 44,772,230 shares after the transaction.

• · Director CERRONE GABRIELE M was awarded 15,000 COMMON STOCK at $1.11 (~$16.7K)

17-06-2026

Waterdrop Inc. announced its first quarter 2026 unaudited financial results via a press release filed as an exhibit to Form 6-K. The filing provides key financial metrics for the quarter ended March 31, 2026, but the specific figures are not included in the cover page. The report was signed by Head of Finance Xiaoying Xu on June 16, 2026.

• · The filing is a Form 6-K for the month of June 2026.
• · The press release (Exhibit 99.1) covers first quarter 2026 unaudited financial results.
• · The report was signed on June 16, 2026.

17-06-2026

CEO Schlachet Amir sold 16,666 Ordinary Shares at $32.18 (~$536K). Schlachet Amir holds 4,200,058 shares after the transaction. Trades executed under a Rule 10b5-1 plan.

• · CEO Schlachet Amir sold 16,666 Ordinary Shares at $32.18 (~$536K)

17-06-2026

CarMax reported Q1 FY27 revenue of $8.0B (+6.2% YoY) and combined unit sales of 392,357 (+3.3% YoY), driven by wholesale unit growth of 8.4%. However, retail used unit sales were essentially flat (+0.04%), comparable store used unit sales declined 0.8%, and gross profit per retail used unit fell $230 to $2,177, reflecting pricing actions. Net earnings per diluted share declined 5.1% to $1.31 from $1.38 a year ago, while SG&A expenses decreased 3.7% to $635.2M, contributing to improved SG&A leverage of $1,619 per total unit.

• · Digital capabilities supported 84% of retail unit sales; omni sales were 70% and online retail sales accounted for 14% of retail unit sales.
• · CAF's provision for loan losses was $95.6M, down from $101.7M a year ago, including a $25.1M release for loans now classified as held for sale.
• · Allowance for loan losses as a percentage of auto loans held for investment increased to 2.95% from 2.78% as of February 28, 2026.
• · CAF's weighted average contract rate was 11.3%, in line with the prior year.
• · No shares were repurchased during Q1 FY27; $1.31B remains available under the authorization.
• · The company plans to host a Strategic Update in late Fall to share additional detail on key initiatives.
• · Second quarter FY27 earnings are scheduled for release on September 29, 2026.
• · Advertising expense increased 11.8% YoY to $75.9M to support sales and buys.
• · Third-party finance fees, net swung to a loss of $4.5M from a loss of $0.7M in the prior year (change of -542.8%).

17-06-2026

Storebrand Asset Management AS filed its 13F-HR for the period ending December 31, 2024, reporting a total of 828 holdings with an aggregate market value of approximately $32.89 billion. The filing shows a diversified portfolio with top holdings in Visa Inc. ($555.3M), Tesla Inc. ($616.1M), UnitedHealth Group Inc. ($284.7M), and Microsoft Corp. ($328.9M). No prior period comparison is available in this filing, so performance trends cannot be assessed.

• · Filing type is 13F-HR for the quarter ended December 31, 2024, filed on June 17, 2026.
• · All 828 holdings are listed with sole voting and dispositive power.
• · Top holdings by value include Tesla ($616.1M), Visa ($555.3M), Microsoft ($328.9M), UnitedHealth ($284.7M), and Alphabet ($267.8M).
• · Other significant positions include Amazon.com ($252.5M), Meta Platforms ($241.0M), NVIDIA ($237.5M), and Apple ($218.9M).
• · The filing does not include any prior period data for comparison.

17-06-2026

Big Digital Energy, Inc. (formerly Mawson Infrastructure Group Inc.) announced on June 17, 2026 that it has regained compliance with Nasdaq Listing Rule 5550(b)(1) after receiving formal notification from Nasdaq. The company had been deficient in stockholders' equity under prior management, but new leadership since early April 2026 has maintained equity above the $2.5 million minimum. However, Nasdaq's determination is subject to the company maintaining at least $5 million in stockholders' equity each quarter for a twelve-month period starting with the quarter ending June 30, 2026, creating ongoing compliance risk.

• · The stockholders' equity deficiency was a legacy issue inherited by the current management team, which assumed control in early April 2026.
• · The company has 129 megawatts of capacity already online with more under development.
• · The company's strategy includes powering operations with carbon-free energy resources, including nuclear power.
• · The company was formerly known as Mawson Infrastructure Group Inc. and changed its name to Big Digital Energy, Inc. on March 22, 2021.

17-06-2026

W. P. Carey Inc. disclosed that its tenant Hellweg Die Profi-Baumärkte GmbH & Co. KG filed for insolvency under self-administration on June 16, 2026. The company net leases 16 properties to Hellweg, representing total annualized base rent (ABR) of approximately $15.2 million, with rent paid through May 2026 and bank guarantees covering three months of rent. W. P. Carey has already executed binding agreements to lease eight of the 16 stores to other home improvement operators at comparable rents, representing ABR of approximately $7.4 million, and is in active negotiations for the re-lease or sale of a majority of the remaining eight stores. The company is maintaining its AFFO guidance range of $5.16 to $5.26 per diluted share for full-year 2026, reflecting estimated potential rent loss from tenant credit events of $8 million to $12 million inclusive of estimated unpaid rents, downtime, and free rent periods.

• · Hellweg filed for insolvency under self-administration on June 16, 2026.
• · Hellweg has paid rent through the end of May 2026.
• · W. P. Carey has bank guarantees covering three months of rent, able to be drawn in the event of unpaid rent.
• · The eight stores with binding agreements represent ABR of approximately $7.4 million.
• · Leases for the eight stores will commence in the event of a lease termination with Hellweg at rents comparable to current rents.
• · Estimated downtime and free rent periods for the eight stores total between three and nine months.
• · W. P. Carey is maintaining its AFFO guidance range of $5.16 to $5.26 per diluted share for the full year ending December 31, 2026.
• · The AFFO guidance reflects estimated potential rent loss from tenant credit events of $8 million to $12 million.